Market open · Delayed intraday data · 2:29 PM ET
Last update: Nov 20, 2026, 2:02 PM ET
UnitedHealth Group Incorporated
$342.80▲ 3.73% today
Market Open

Why UnitedHealth Group Incorporated (UNH) stock moved

Latest session▼ 5.6% · Nov 19, 2026 close

Why UnitedHealth Group Incorporated (UNH) fell 5.6% on November 19, 2026

UnitedHealth Group Incorporated (UNH) fell 5.6% on November 19, 2026, closing at $330.48 versus $349.91 the prior session (close-to-close, from daily closes). As investors reacted to the CMS CRUSH proposal for expanded Medicare Advantage audits and retroactive clawbacks dating back to 2018, per Barron's reporting cited by Google's AI Overview. The proposal could extract ~$9 billion annually in recoveries across federal programs, with UnitedHealth—the largest Medicare Advantage operator—facing material repayment exposure and margin pressure. Source: barrons.com.

Updated
Prior close
$349.91
Nov 19, 2026 close
$330.48
Change (close-to-close)
−$19.43
−5.55%
As first detected · Nov 19, 2026, 10:02 AM ET

UnitedHealth Group shares fell 5.40% to $331.03 on November 19, 2026, as investors reacted to the CMS CRUSH proposal for expanded Medicare Advantage audits and retroactive clawbacks dating back to 2018, per Barron's reporting cited by Google's AI Overview. The proposal could extract ~$9 billion annually in recoveries across federal programs, with UnitedHealth—the largest Medicare Advantage operator—facing material repayment exposure and margin pressure. Volume of 5.67 million shares was 4.40x the expected intraday average at 90 minutes, reflecting elevated selling pressure.

What to watch next: UnitedHealth earnings on January 20, 2027 (consensus EPS: $2.28); CMS formal comment period and final rule timeline for the CRUSH audit proposal.

Source: barrons.com · percentages in this note are as captured at detection; the confirmed close-to-close move is shown above.

Earlier sessions that moved UNH

  1. −10.2%UnitedHealth Group fell 10.2% on November 18, 2026, driven by federal regulatory pressure on Medicare Advantage and political headwinds for private insurers. Read the November 18, 2026 analysis →
  2. −5.4%We checked news, earnings, analyst updates, filings, and corporate actions.
  3. −3.3%We checked news, earnings, analyst updates, filings, and corporate actions.
  4. +3.0%Following a wave of analyst price-target increases from RBC Capital, Piper Sandler, and KeyBanc in the wake of its strong Q3 earnings report (investing.com).
  5. +2.8%Following a strong Q3 earnings beat announced October 14, 2026.
  6. +4.7%UnitedHealth Group filed an 8-K material event report and confirmed an earnings report today, driving a 3.44% intraday rally to $390.74 from $377.76.

UnitedHealth Group Incorporated (UNH) shares rose 3.7% to $342.80 as of November 20, 2026, a moderate gain from the prior close of $330.48. BestStocks flagged the session as a major change for UNH. Below, we break down what changed for UNH, why it matters for investors, how the stock reacted, and the catalysts on the calendar.

What happened

UNH climbed 3.7% to $342.80

UNH rose 3.7% in its latest session, moving from $330.48 to $342.80.

RiskCompany-Specific MoveMedium confidence
Rel. volume
1.6×
Above Avg
Vs peers
Top 1 of 7 peers
Outperforming
Market cap
$307.2B
New York Stock Exchange
Analyst target
$478
+39.3% vs price
Price chart
Oct 20 – Nov 20
VVNNNFNNVF$330$378$426Oct 20Oct 28Nov 5Nov 12Nov 20
E earnings
F filing
A analyst
V/N other
click a marker to highlight
Change events — click to jump to details

What it means for UnitedHealth Group Incorporated investors

For UnitedHealth Group Incorporated investors, the recent signals are mixed, leaving the near-term picture neutral / mixed. On the constructive side: Positive 3.7% session move; Positive price momentum. Weighing against that: UnitedHealth Group shares fell 5.40% to $331.03 on November 19, 2026, as investors reacted to the CMS CRUSH proposal for expanded Medicare Advantage audits and retroactive clawbacks dating back to 2018, per Barron's reporting cited by Google's AI Overview; UnitedHealth Group fell 6.95% to $362.61, declining nearly $27 per share on elevated volume (2.68x expected for this time of day). Because the move outpaced peers, it looks driven by UNH-specific developments rather than a broad sector rotation. Wall Street's consensus price target sits at $477.50, implying +39.3% upside from $342.80. BestStocks rates the overall signal quality medium (67/100). With earnings roughly 61 days out, the next report is the most likely near-term test of the move.

UNH price reaction

UNH last traded at $342.80, up $12.32 (+3.73%) from the previous close of $330.48. The session traded on 1.6× average volume (above avg), so the move carried above-average conviction. Its healthcare peer group moved a median +1.3% over the same stretch, leaving UNH ahead of the group by 2.4 points. Over the past month the stock has ranged between $330.48 and $424.98, and it currently sits about 13% of the way up that band.

Bullish and bearish analyst opinions on UnitedHealth Group Incorporated (UNH)

The consensus analyst price target on UnitedHealth Group Incorporated (UNH) is $477.50, 39.3% above the recent $342.80. Over the past 90 days analysts logged 0 upgrades, 11 maintains, and 0 downgrades. Here is how the bullish and bearish cases on UNH line up.

The bullish case

  • Wall Street's consensus price target of $477.50 implies +39.3% upside from $342.80.
  • The Street's most bullish target is $531.00 (+54.9%).
  • Positive 3.7% session move.
  • Positive price momentum.

The bearish case

  • UnitedHealth Group shares fell 5.40% to $331.03 on November 19, 2026, as investors reacted to the CMS CRUSH proposal for expanded Medicare Advantage audits and retroactive clawbacks dating back to 2018, per Barron's reporting cited by Google's AI Overview.
  • UnitedHealth Group fell 6.95% to $362.61, declining nearly $27 per share on elevated volume (2.68x expected for this time of day).
Bull vs bear balanceNeutral / Mixed
BearishNeutralBullish

Weighing both sides, BestStocks' composite read of recent signals is roughly balanced, as the bull-versus-bear meter above shows. This is an educational summary of the bull and bear case, not investment advice.

Analyst price targets and ratings are FMP consensus figures as of Nov 20, 2026; other aggregators may differ. High and low targets show the range of estimates, not forecasts.

Analyst expectations
Consensus target: $478+39.3%
= 11 maintains
Morgan Stanley maintained Overweight · 2026-10-27
SEC filings watch
8-K2026-11-09
Material event — review for impact
high
10-Q2026-11-03
Quarterly financial results
medium
8-K2026-10-13
Material event — review for impact
high
8-K2026-09-08
Material event — review for impact
high
Peer context
UNH+3.7%
LLY-0.0%
JNJ+1.8%
PFE+0.1%
ABBV+1.8%
MRK+1.3%

Previous notable changes for UNH

Risk2026-11-18-10.2%via Business Wire ↗
UnitedHealth Group fell 6.95% to $362.61, declining nearly $27 per share on elevated volume (2.68x expected for this time of day). No major negative catalyst appeared in news flow; a UnitedHealthcare announcement on rural pharmacy access and commentary on 13–16% long-term earnings growth targets were published, but neither explains the sharp intraday drop. The selloff occurs amid broad market conditions and ahead of UNH's January 20 earnings release.
News2026-11-18-10.2%
UnitedHealthcare partners with CPESN to expand care delivery through independent pharmacies in rural, underserved areas.
News2026-11-09+0.9%
Madeline Bell, former CHOP president and CEO, joins UnitedHealth Group's Board of Directors effective immediately.
Filings2026-11-09+0.9%
UnitedHealth Group Incorporated (UNH) filed a new 8-K on November 9, 2026. We reviewed the filing announcement, earnings calendar, and recent news — no specific disclosure details or triggering event from the 8-K were identified in available data.

In-depth UNH event analyses

Permanent, dated analyses of UNH's most significant sessions.
Upcoming catalysts & outlook
Next earnings
2027-01-20 (est.)
in 61 days
10-Q Filing (est.)
2027-02-02
Medium impact
Thesis shift
Neutral / Mixed
bearish signal
Risk level
High
from change events

Frequently asked questions about UNH

Why did UnitedHealth Group Incorporated (UNH) stock move?

UnitedHealth Group Incorporated (UNH) fell 5.6% on November 19, 2026, closing at $330.48 versus $349.91 the prior session (close-to-close, from daily closes). As investors reacted to the CMS CRUSH proposal for expanded Medicare Advantage audits and retroactive clawbacks dating back to 2018, per Barron's reporting cited by Google's AI Overview. The proposal could extract ~$9 billion annually in recoveries across federal programs, with UnitedHealth—the largest Medicare Advantage operator—facing material repayment exposure and margin pressure. Source: barrons.com.

How much did UNH stock rise?

UNH gained 3.73% ($12.32) versus the prior close of $330.48, last trading at $342.80 on 1.6× average volume.

When is UnitedHealth Group Incorporated's next earnings date?

UNH's next earnings report is estimated for 2027-01-20 — about 61 days away.

What is the analyst price target for UNH?

The consensus analyst price target for UNH is $477.50, about 39.3% above the current $342.80. Over the past 90 days, analysts recorded 0 upgrades, 11 maintains, and 0 downgrades.

Is the UNH move company-specific or sector-wide?

BestStocks classifies it as a company-specific move: the peer group moved a median +1.3% against UNH's +3.7%. UNH ranks top 1 of 7 peers.

How BestStocks tracks UNH

This page is generated automatically by BestStocks' change-detection system after its price and volume cleared UNH-specific materiality thresholds, triggering an evidence check. It draws on 20 tracked change events for UNH, cross-checked against the data sources listed below. Price, volume, and market-capitalization figures are the live intraday quote as of November 20, 2026 and refresh as new information is detected; for companies with multiple share classes, market-cap figures can differ by data source. Analyst price targets and ratings are FMP consensus. This is an educational summary of what changed and why — not personalized investment advice.

Data sources
FMP real-time & historical price dataSEC EDGAR filingsCompany news feedsFMP earnings & estimatesAnalyst ratings & price targets (FMP)Earnings calendar (FMP)
Educational research tool — not personalized investment advice. Data may be delayed.